Celltrion Healthcare’s ‘Truxima’ expanded to 18 European countries only in 1 year
Celltrion Healthcare is quickly extending the rage of its European distribution network for ‘Truxima(generic name: rituximab),’ an antibody biosimilar for hematologic malignancies.
According to Celltrion Healthcare, they launched ‘Truxima’ in the U.K. for the first time Europe, completed the lau...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.